Peer-influenced content. Sources you trust. No registration required. This is HCN.
Annals of Internal Medicine
Data to support the use of hydroxychloroquine (HCQ) and chloroquine (CQ) for COVID-19 are limited and inconclusive; this article from the American College of Physicians (ACP) discusses the facts to arm yourself with the proper information.
Allergy & Immunology April 13th 2020
The University of Nebraska Medical Center’s innovative decontamination procedure involving the delivery of ultraviolet germicidal irradiation to used N95 masks has shown great promise in the fight against the shortage of PPEs.
Family Medicine/General Practice April 13th 2020
JAMA Network
A comprehensive guide from the American Medical Association (AMA), which includes information for those who want to support communities severely impacted by COVID-19, including the how and where to volunteer and all things to consider.
Although researchers emphasized more research is necessary, a study in Blood Advances demonstrated that tocilizumab may be an effective treatment for patients with COVID-19 and hematologic malignancies.
Hematology April 6th 2020
Oncology healthcare providers must consider a trio of specific management strategies for their patients during this time, as COVID-19 can be particularly lethal in patients with cancer.
Geriatrics April 6th 2020
Despite a small sample size, a recent trial demonstrated hydroxychloroquine treatment’s effect reinforced by azithromycin is significantly associated with viral load reduction/disappearance in COVID-19 patients.
Allergy & Immunology March 30th 2020